卓越教育集團(03978.HK)獲納入MSCI(明晟)中國全股票小型股指數
格隆匯5月14日丨卓越教育集團(03978.HK)公佈,公司獲納入MSCI(明晟)中國全股票小型股指數成份股,自2020年5月29日收市開始生效。
MSCI明晟即美國著名的指數編制公司摩根斯坦利資本國際,其中國全股票小型股指數乃為計量中國市場小型股的表現而設,涵蓋了具有良好經營業績和潛力的公司,具有較高參考價值。董事會相信,公司獲納入MSCI(明晟)指數凸顯了國際資本市場對中國教育行業的關注,反映了資本市場對公司投資價值的認同,預期將有助提升公司關注度,及增加公司的買賣流動性,更好實現股東的投資價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.